Godrej Agrovet Limited has informed the Exchange about Transcript

Godrej Agrovet delivered strong Q4 FY '26 with consolidated revenues of INR 2,333 crores (up 9% YoY) and PBT of INR 87 crores (up 16.8% YoY). For full year FY '26, the company surpassed INR 10,000 crores in revenues at INR 10,233 crores with 17.2% PBT growth to INR 569 crores. Key segment highlights include Animal Nutrition volumes growing 15% YoY with cattle feed up 24%, while Crop Care faced headwinds from co-marketing inventory issues. Astec LifeSciences achieved EBITDA break-even in FY '26 driven by CDMO momentum. Management guided for FY '27 targeting mid-teens PBT growth and early double-digit revenue growth, with capex of INR 400 crores and expected free cash flow surplus of INR 100-125 crores after capex.